• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 1163 Show All Page 1 of 24
GRN No. Substance
(sorted A-Z)
Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  617
α-amylase from Cytophaga sp. produced in Bacillus licheniformis Apr 8, 2016 At the notifier's request, FDA ceased to evaluate this notice
  594
α-amylase from Geobacillus stearothermophilus produced in Bacillus licheniformis Dec 18, 2015 FDA has no questions
  1120
α-galactosidase enzyme preparation produced by Aspergillus niger Pending
  1109
β-agarase enzyme preparation produced by Streptomyces coelicolor Pending
  649
β-galactosidase enzyme preparation from Bacillus circulans produced in Bacillus subtilis Nov 28, 2016 FDA has no questions
  743
β-galactosidase from Papiliotrema terrestris Jun 1, 2018 FDA has no questions (in PDF) (68 kB)
  961
β-glucan derived from Agrobacterium sp. CCTCC No. M2010020 May 19, 2021 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (229 kB)
  592
β-glucanase from Bacillus subtilis Oct 7, 2015 FDA has no questions
  995
β-glucans from Antrodia cinnamomea strain ATCC 200183 Jun 14, 2022 FDA has no questions (in PDF) (162 kB)
  1124
β-glucans from Hericium erinaceus strain BCRC 35669 Sep 28, 2023 At the notifier's request, FDA Ceased to evaluate this notice (in PDF) (209 kB)
  544
β-glucans from oat bran May 5, 2015 FDA has no questions
  1005
β-Lactoglobulin from cow milk Mar 3, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF)
  1145
β-lactoglobulin produced by Aspergillus oryzae strain Ao_st0002 Pending
  1056
β-lactoglobulin produced by Komagataella phaffii strain yRMK-66 Feb 15, 2023 FDA Has No Questions (in PDF) (291 kB)
  863
β-lactoglobulin produced by Trichoderma reesei Mar 25, 2020 FDA has no questions (in PDF) (637 kB)
  135
ε-Polylysine Jan 16, 2004 FDA has no questions
  336
ε-Polylysine (polylysine) Aug 24, 2011 FDA has no questions
  82
1,1,1,2-Tetrafluoroethane (HFC-134a) Jun 5, 2002 FDA has no questions
  302
1,3-propanediol Mar 5, 2010 FDA has no questions
  361
1,4-α-D-glucan branching enzyme preparation Jan 31, 2011 At the notifier's request, FDA ceased to evaluate this notice
  406
1,4-α-glucan branching enzyme preparation from Bacillus subtilis strain 168 expressing the glucan branching enzyme gene from Aquifex aeolicus strain VF5 Sep 11, 2012 FDA has no questions
  405
1,4-α-glucan branching enzyme preparation from Geobacillus stearothermophilus strain TRBE14 Sep 11, 2012 FDA has no questions Dec 15, 2014
  585
1-methylcyclopropene Jan 29, 2016 FDA has no questions
  1155
1-methylcyclopropene Pending
  897
2'-O-fucosyllactose Jun 12, 2020 FDA has no questions (in PDF) (715 kB)
  650
2'-O-fucosyllactose Nov 23, 2016 FDA has no questions Sep 11, 2020
Sep 9, 2020
  852
2'-fucosyllactose Nov 15, 2019 FDA has no questions (in PDF) (108 kB)
  859
2'-fucosyllactose Sep 6, 2019 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (106 kB)
  924
2'-fucosyllactose Nov 23, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF)
  929
2'-fucosyllactose Feb 26, 2021 FDA has no questions (267 kB)
  932
2'-fucosyllactose Feb 18, 2021 FDA has no questions (in PDF) (223 kB)
  987
2'-fucosyllactose Feb 2, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (236 kB)
  1034
2'-fucosyllactose Oct 21, 2022 FDA has no questions (in PDF) (258 kB)
  1040
2'-fucosyllactose Sep 22, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (116 kB)
  1060
2'-fucosyllactose Apr 4, 2023 FDA has no questions (in PDF) (333 kB)
  1091
2'-fucosyllactose Pending
  1157
2'-fucosyllactose Pending
  1051
2'-fucosyllactose Nov 21, 2023 FDA has no questions (in PDF) (298 kB)
  735
2'-Fucosyllactose Apr 6, 2018 FDA has no questions (in PDF) (103 kB) Apr 30, 2020
  571
2'-Fucosyllactose Nov 6, 2015 FDA has no questions Nov 8, 2019
  815
2'-fucosyllactose and difucosyllactose Aug 20, 2019 FDA has no questions (in PDF) (250 kB) Sep 11, 2020
May 7, 2020
  546
2'-O-fucosyllactose Sep 16, 2015 FDA has no questions
  749
2'-O-fucosyllactose Apr 23, 2018 FDA has no questions (in PDF) (95 kB)
  1014
2-fucosyllactose Jul 15, 2022 FDA has no questions (in PDF) (295 kB)
  766
3'-sialyllactose sodium salt Sep 26, 2018 FDA has no questions (in PDF) (920 kB)
  880
3'-sialyllactose sodium salt Feb 21, 2020 FDA has no questions (in PDF) (557 kB)
  921
3'-sialyllactose sodium salt Oct 30, 2020 FDA has no questions (in PDF) (771 kB)
  1015
3'-sialyllactose sodium salt Jul 15, 2022 FDA has no questions (in PDF) (234 kB)
  1052
3'-sialyllactose sodium salt Apr 18, 2023 FDA has no questions (in PDF) (292 kB)
  1074
3'-sialyllactose sodium salt Apr 5, 2023 FDA has no Questions (in PDF) (383 kB)

Show All 

jump to page of 24 


GRN No. Substance
(sorted A-Z)
Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-